Voruciclib(P1446A-05) is a small molecule flavone derivative, a pan inhibitor of CDK with Ki’s of 0.626 nM-9.1nM, that potently targets CDK9, represses expression of MCL-1 and leads to tumor cell apoptosis and tumor growth inhibition in multiple models of diffuse large B-cell lymphoma (DLBCL).